American Society of Clinical Oncology Statement: A Conceptual Framework to Assess the Value of Cancer Treatment OptionsLowell E. Schnipper, Richard L. Schilsky, J. Russell Hoverman et al.|Journal of Clinical Oncology|2015Cited by 903
Updating the American Society of Clinical Oncology Value Framework: Revisions and Reflections in Response to Comments ReceivedLowell E. Schnipper, Richard L. Schilsky, Nancy E. Davidson et al.|Journal of Clinical Oncology|2016Cited by 654
American Society of Clinical Oncology Guidance Statement: The Cost of Cancer CareNeal J. Meropol, Lowell E. Schnipper, Deborah Schrag et al.|Journal of Clinical Oncology|2009Cited by 635
Response-guided neoadjuvant sacituzumab govitecan for localized triple-negative breast cancer: results from the NeoSTAR trialLaura M. Spring, Aditya Bardia, Sara M. Tolaney et al.|Annals of Oncology|2023Cited by 77